ConductScience.org, home

Trial · NCT03150511

Tesamorelin to Improve Functional Outcomes After Peripheral Nerve Injury

NCT03150511, Phase 2, Recruiting, Johns Hopkins University

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Tesamorelin to Improve Functional Outcomes After Peripheral Nerve Injury. Trials, record NCT03150511. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03150511

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Tesamorelin to Improve Functional Outcomes After Peripheral Nerve Injury
NCT number
NCT03150511
Status
Recruiting
Phases
Phase 2
Enrollment
36 participants, estimated
Lead sponsor
Johns Hopkins University
Conditions
Peripheral Nerve Injuries
Interventions
Tesamorelin 2 Milligrams (MG)
First posted
2017-05-12
Last updated
2026-11-09

Source ClinicalTrials.gov

Registered outcomes8

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
Primary3-point chuck pinch test12 monthsPinch strength measure as measured by a pinch gauge.
SecondaryDisability of the Arm, Shoulder, and Hand (DASH) score12 monthsQuestionnaire
SecondaryMichigan Hand Questionnaire score12 monthsQuestionnaire
SecondaryAmplitude of response12 monthsNerve conduction study measure
SecondaryLatency of response12 monthsNerve conduction study measure
SecondaryVelocity of response12 monthsNerve conduction study measure
SecondaryModified British Medical Research Council (MBMRC) sensory grading (S0-S4)12 monthsStandardized clinical assessment of sensory function using 2-point discrimination and monofilament testing. S0 indicates no recovery and S4 indicates full recovery.
SecondaryModified British Medical Research Council (MBMRC) motor grading (M0-M5)12 monthsStandardized clinical assessment of motor function. M0 indicates no muscle contraction and M5 indicates active range of motion against strong resistance.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT03150511

GET https://conductscience.org/api/trials/v1/NCT03150511/registered